Back to search

Article

Atractylenolide III predisposes miR-195-5p/FGFR1 signaling axis to exert tumor-suppressive functions in liver cancer

2020-08-12

Abstract excerpt

<h4>Background: </h4> Antineoplastic activity of atractylenolide III (ATL) has been reported in several malignant tumors. However, its activity has not been completely clarified in hepatocellular carcinoma (HCC). Herein, anti-cancer effects and underlying molecular mechanisms of ATL were investigated in HCC cells in vitro. <h4>Methods: </h4>: Cell viability was evaluated by CCK-8 assay. Cell migration and invasion...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5c763d1f-e7b6-5599-9efa-3d97e27f77af
DOI
10.21203/rs.3.rs-56832/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Atractylenolide III predisposes miR-195-5p/FGFR1 signaling axis to exert tumor-suppressive functions in liver cancerDOI 10.21203/rs.3.rs-56832/v1
Select a neighboring publication to make it the new centre.